Belvedere Trading LLC Biotechnology

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
SAVA
Cassava Sciences Inc
CALL
$2.41 Million
82K
Q2 2024
New holding
SAVA
Cassava Sciences Inc
PUT
$932,000
31.7K
Q2 2024
New holding
SMMT
Summit Therapeutics Inc.
CALL
$508,000
23.2K
Q3 2024
New holding
VKTX
Viking Therapeutics, Inc.
CALL
$487,000
7.7K
Q2 2024
New holding
SMMT
Summit Therapeutics Inc.
PUT
$424,000
19.4K
Q3 2024
New holding
BBIO
Bridge Bio Pharma, Inc.
CALL
$353,000
13.9K
Q2 2024
Added 2.58%
PCVX
Vaxcyte, Inc.
PUT
$296,000
2.6K
Q2 2024
Reduced 14.92%
PCVX
Vaxcyte, Inc.
CALL
$285,000
2.5K
Q2 2024
Reduced 14.92%
ITOS
I Teos Therapeutics, Inc.
PUT
$231,000
22.7K
Q2 2024
Reduced 39.13%
PTGX
Protagonist Therapeutics, Inc
CALL
$206,000
4.6K
Q1 2023
New holding
AVXL
Anavex Life Sciences Corp.
CALL
$130,000
23K
Q3 2022
New holding
FULC
Fulcrum Therapeutics, Inc.
CALL
$51,000
14.4K
Q2 2024
New holding
RLMD
Relmada Therapeutics, Inc.
CALL
$42,000
13.2K
Q2 2024
New holding
BBIO
Bridge Bio Pharma, Inc.
PUT
$40,000
1.6K
Q2 2024
Added 2.58%
PTGX
Protagonist Therapeutics, Inc
PUT
$8,000
200
Q1 2023
New holding
FULC
Fulcrum Therapeutics, Inc.
PUT
$8,000
2.4K
Q2 2024
New holding
CLDX
Celldex Therapeutics, Inc.
PUT
$3,000
100
Q4 2021
Closed
ITOS
I Teos Therapeutics, Inc.
CALL
$2,000
200
Q2 2024
Reduced 39.13%
Filter Shares Options
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email